Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Tables)

v3.21.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Schedule of Stock-based Compensation

Stock-based compensation, including restricted stock awards, stock options and warrants is included in the unaudited condensed consolidated statement of operations as follows:

 

    Three Months Ended March 31,  
    2021     2020  
Research and development   $ 23,486     $ 15,872  
Sales and marketing     63,449       34,584  
General and administrative     1,612,488       106,002  
Total   $ 1,699,423     $ 156,458  
Schedule of Stock-based Compensation, Stock Options, Activity

The following table reflects the stock option activity:

    Number of Shares     Weighted Average Exercise Price     Contractual Life (Years)  
Outstanding at December 31, 2020     1,920,269     $ 4.40       8.66  
Exercised     (74,987 )     (2.45 )        
Outstanding at March 31, 2021     1,845,282     $ 4.48       8.47  
Schedule of Stock-based Payment Award, Stock Options, Valuation Assumptions

The Company uses the following inputs when valuing stock-based awards.

 

    Three Months Ended March 31,  
    2021     2020  
Expected life (years)     0.0       5.0  
Risk-free interest rate     0 %     0.29 %
Expected volatility     0 %     74.4 %
Total grant date fair value   $ 0.00     $ 0.99  
Restricted Common Stock [Member]  
Schedule of Stock-based Compensation, Stock Options, Activity

The following table reflects the restricted stock activity:

 

 

Number of

Shares

    Weighted Average Grant Price  
Outstanding at December 31, 2020     1,072,503     $ 5.30  
Granted     172,000     $ 7.66  
Outstanding at March 31, 2021     1,244,503     $ 5.63